cccDNA/HBsAg inhibitors (Biotron)

N/A

Report date: 2025/03/19 08:59:46
NME

Base Information

Drug NamecccDNA/HBsAg inhibitors (Biotron)
Drug Alias Nameantiviral therapeutics (Biotron)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg modulators
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotron
China Registration ClassN/A

Develop Information

Active CompaniesBiotron
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A